Review
of oligo saccharides has become possible [4] , carbohydrate-based vaccines have been developed [5] and high-throughput methods have been designed for the screening of molecular interactions [6] . The exciting new developments in glycoscience are opening way for new challenges in exploring the full potential of carbohydrates in molecular imaging. Therefore, here we give an overview of the recent literature on the use of glycoconjugates either as probes or targets in molecular imaging using MRI.
MRI contrast agents (CAs) are broadly described as positive or negative, depending on whether they give rise to a brightening or a darkening effect on the MR image, respectively. The positive or brightening effect predominantly relates to the longitudinal proton relaxation time (T 1 ) and the negative or darkening effect predominantly relates to the transverse proton relaxation time (T 2 ). To date, the majority of commercially available and clinically applied positive CAs are Gd 3+ complexes of the polyaminocarboxylates diethylene triamine pentacetic acid (DTPA) and 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) (see FiguRe 1 for some typical examples) and negative CAs are various iron oxide particles. These agents are not actively targeting. The targeted CAs for application in molecular imaging that are currently under development and described below are generally based on compounds 1 (Gd-DTPA) and 2 (Gd-DOTA), as well as iron oxide nanoparticles.
Glycoconjugate probes and targets for molecular imaging using magnetic resonance 
410
future science group
Ln-chelate glycoconjugates as molecular imaging CAs
Ln-chelate glycoconjugates as CAs for liver imaging using lectins as targets Lectins are carbohydrate-binding proteins that specifically bind to the oligosaccharide moieties of glycoproteins and glycolipids. They also have the capability of recognizing a large variety of natural and artificial polysaccharidelike molecules with various different structures, such as heparin sulphate and hyaluronic acid proteoglycans [7] [8] [9] . A cluster glycoside effect, which describes the affinity enhancement (typically of orders of magnitude) involved in multi valent binding of several carbohydrate residues [10] , has been found to operate in these lectin-carbohydrate interactions. Individual CRDs interact specifically with sugars (e.g., glucose, mannose and galactose) with affinity constants (lectin-monomeric sugar) in the millimolar range. However, assembly of monomeric units in oligomeric lectins results in the display of an array of CRDs with a variety of topologies, which, together with the topology (relative orientation and spacing) of the glycoconjugate carbohydrate residues, critically determines the specificity and strength of lectin-carbohydrate interactions [7, 10, 11] . Numerous synthetic multivalent glycopolymers and dendrimers displaying this effect have been developed for the targeting of cell/organ specific lectins for drug-delivery purposes and for the inhibition of cell-cell or cell-foreign body (bacteria/virus) interactions [10, [12] [13] [14] .
The capacity of the hepatic asialoglycoprotein receptor (ASGP-R) to recognize terminal b-galactosyl and b-N-acetyl-galactosaminyl residues on desialylated glycoproteins [15] can be used for liver targeting of artificial glyco conjugates. This has been successfully achieved with galactose/lactosecontaining glycoconjugates, with a multivalence effect (tetra > tri > di > mono) on liver uptake [16] . The functional imaging of liver ASGP-R is of both diagnostic and prognostic value during the treatment of liver pathologies (e.g., cancer and hepatitis B). Several hepatic imaging agents have been described that rely on macromolecular bioconjugates and polymer scaffolds as carriers, bearing efficient reporter groups and pendant b-galactoside and/or N-acetyl-b-galactosaminyl residues as targeting groups of the ASGP-R. A conjugate of a neoglyco protein, galactosylated serum albumin (GSA), with [ Tc]-DTPA-GSA [17] , has been used in single photon emission computed tomography (SPECT) hepatic imaging of rodents and humans to study liver pathologies [18] [19] [20] [21] . The hepatocyte-specific nature of the ASGP-R and the fact that it is still expressed (although in reduced numbers) on hepatoma cells makes it possible to detect liver-cancer metastases to other organs, such as bone [22] . The [ 111 In]-DTPA-GSA analogue has also been used in mouse liver SPECT imaging [23] .
Two classes of potential CAs for liver MRI through targeting of the hepatocyte ASGP-R have also been developed and tested in cells and mice:
Macromolecular: a Gd-DTPA conjugate of polylysine (PL) derivatized with galactosyl groups (Gd-DTPA-gal-PL) [24] and a spin-labeled arabinogalactan [25] ;
Particulate systems: monocrystalline iron oxide nanoparticles (MION) conjugated to the bovine plasma protein asialofetuin (ASF), MION-ASF [26] ;
Arabinogalactan (AG)-coated ultrasmall superparamagnetic iron oxide particles (USPIO) (FiguRe 2 ) [27] [28] [29] [30] . 
MoleculaR Recognition
The specific interaction between two or more molecules through noncovalent bonding, which plays a major role in biological processes
MRi contRast agents
Paramagnetic materials that decrease the NMR relaxation times of water protons, resulting in the increase of the contrast in MRI images. These materials include Gd(III)-complexes and iron oxide particles Both the macromolecular and particle-based ASGP-R-targeted imaging agents described above include carriers bearing multiple reporter groups and a multivalent display of galactosyl-targeting groups.
However, these agents have the drawback of being inherently polydisperse and ill characterised. Chemically well-defined, mono disperse and characterized multivalent agents can be assembled by an alternative molecular design: the conjugation of dendrimeric-clustered carbohydrate bifunctional reagents through spacers to an MRI reporter group. Various Gd(III) complexes of the DTPA-and DOTA-type ligands, peripherally substituted with one or more targeting group(s) consisting of a clustered carbohydrate of variable valence, with different topologies (FiguRe 3) , containing an increasing number of terminal galactosyl (Gal), lactosyl (Lac) or glycosyl (Glc) groups, have been synthesized and studied [31] [32] [33] [34] [35] [36] . The ligands included various DOTA monoamide derivatives (FiguRe 4), with one (DOTAGal, DOTAGlc and DOTALac; 9), two (DOTAGal 2 , DOTAGlc 2 and DOTALac 2 ;10) or four (DOTAGal 4 ; 12) terminal sugar groups, one DOTA cis-bisamide derivative with two terminal sugar groups (DO2A(cis)Gal 2 ; 11) and DTPA bisamides with two (DTPAGal 2 and DTPALac 2 ; 13) or four (DTPAGal 4 ; 14) terminal sugar groups. All dendrimeric sugar units were bound thioglycosidically, in order to prevent them from being cleaved off by enzymes [32] [33] [34] [35] . The 1 H nuclear magnetic relaxation dispersion (NMRD) profiles showed that the relaxivity increase of these compounds relative to the respective parent compounds without the sugar derivatives (Gd-DOTA; 2 and Gd-DTPA-BMA; 3) is much lower that that expected for their molecular weight increase [32, 33] . As an example, at 20 MHz and 298 K, r 1 of Gd-DTPALac 2 is only 13% higher than that of Gd-DTPA-BMA, although its molecular weight is approximately three-times higher [33] . An evaluation of the parameters governing their relaxivity showed that r 1 of these Gd(III) complexes of glycoconjugate ligands is limited by:
Slow water exchange (the residence time of water in the first coordination sphere, t M is approximately 830 ns for Gd-DOTA derivatives and t M is approximately 25 µs for Gd-DTPA-BMA derivatives); Fast overall rotational dynamics; due to the high internal mobility of the sugar side chains and of the spacers that connect them to the Adapted with permission from [31] .
future science group more rigid part of the chelate, which are located at positions that do not allow an effective coupling between the Gd-OH 2 vector and the tumbling motion of the whole complex;
Nonoptimal electron-spin relaxation due to their asymmetric Gd(III)-coordination cage [32, 33] .
This new class of hydrophilic liver-targeted agents was evaluated in vivo by imaging techniques in Wistar rats and mice. In order to be able to compare the results for MRI with g-imaging studies of the corresponding Gd(III) complexes, the ligands were complexed to the g-emitting 153 Sm(III) nuclide [34, 35] . The results show that the liver uptake of the labeled compounds depends on their valency, sugar type and topology. They are prime examples of the aforementioned cluster glycoside effect. After 24 h postinjection in Wistar rats, the compounds bearing four galactose residues clearly show a much better enrichment in the liver than the mono-or di-substituted systems, indicating that binding to the ASGP-R occurs in a multivalent fashion. The affinity decreases if lactose is attached and is at its lowest for the glucosederived compounds. The dendrimeric topology of DOTAGal 2 has a higher targeting efficiency than that of the DO2A(cis)Gal 2 . Blocking the ASGP-R in vivo with the presence of its highaffinity ligand asiolofetuin (ASF)-reduced liver uptake by 90%, strongly suggesting that the liver uptake of these compounds is mediated by their binding to ASGP-R.
However, despite the specific liver uptake of the radiolabeled galactosyl-bearing compounds, a dynamic contrast-enhanced (DCE) MRI assessment of the corresponding Gd(III) chelates in mice showed liver-to-kidney contrast effects that are not significantly better than those shown by Gd-DTPA [35] . This probably results from the quick wash-out from the liver of these highly hydrophilic complexes, before they can be sufficiently concentrated within the hepatocytes via receptor-mediated endocytosis.
Gd(III) complexes that combine a symmetrically substituted structure and a fast inner-sphere water exchange with an effective motional coupling, as described above, have been synthesized and studied ( FiguRe 5 ) [36] . It concerns two types of Gd-DOTA complexes, a-substituted at the four pendant acetate arms with dendrimeric sugar structures (15 & 16) [36] shows that this can be rationalized by:
Optimized water exchange rate (t M ~198-221 ns); Slow rotational dynamics due to their very compact and symmetrical structure;
A high contribution to r 1 from water molecules in the second coordination sphere of Gd(III), hydrogen-bonded to the hydroxyl groups of the sugars.
In MRI experiments at 2 T with a mouse model of a mammary tumor expressing the HER-2/neu receptor, complex 15 showed a stronger and longer-lived signal enhancement of the tumor area compared with the commercial CA Gd-HPDO3A at the same dose, excretion primarily via the renal system, and no liver retention (FiguRe 6) [36] . However, this preliminary study did not assess the binding affinity of 15 to the HER-2/neu receptor in vitro. A similar MRI study undertaken with the b-galactosyl analogue of complex 16 [36] showed no significant signal enhancement of the liver, despite the presence of the 12 peripheral galactosyl units. These results may mean that this compound and compounds 9-14 are too hydrophilic to be efficiently concentrated within the hepatocytes via ASGP receptor-mediated endocytosis.
Prior to these studies, only a low-molecular weight, well-characterized, monomeric [
111 In]-radiolabeled galactopyranosyl conjugate of DOTA for scintigraphic applications using the targeting of the ASGP-R both in hepatic cell lines and mice had appeared in the literature [37] .
Relaxivity
Relaxivity (r 1 or r 2 ) of a contrast agent is the increase of relaxation rate (1/T 1 or 1/T 2 , where T 1 and T 2 are the longitudinal and transverse relaxation times) of water protons per mM of contast agent
asialoglycopRotein ReceptoR
Organ-specific heterooligomeric lectin that is only expressed at the surface of hepatocyte cells of the liver, it recognizes terminal b-galactosyl and b-N-acetyl-galactosaminyl residues on desialylated glycoproteins. It is involved in selective removal of the glycoproteins, with those exposed terminal residues, from serum Ln-chelates conjugated with Sialyl-Lewis X mimics to target inflammation Selectins are a family of adhesion molecules that mediate the initial attachment of leukocytes to activated endothelial cells in response to inflammation and tissue injury. Of the three closely related cell-surface selectins, L-selectin, P-selectin and E-selectin, the two latter selectins are expressed by vascular endothelial cells while l-selectin is expressed on leukocytes. Selectin expression is strongly induced by inflammatory mediators and the activated endothelial cells FiguRe 7; 17) , on the surface of monocytes, neutrophils, basophils, eosinophils, and a specific subset of T-lymphocytes plays an important role in inflammation and in many immune system mediated diseases including rheumatoid arthritis and cancer metastasis. Much research has been devoted to the design as well as the synthesis of sialyl mimetics, with the aim of using them as inhibitors of sLe x -E-selectin binding [38] .
Molecular modeling based on the x-ray structure of E-selectin and an NMR study of the conformation of bound sLe x has led to the rational design of a series of low-molecular weight mannose-based inhibitors with structure 18 [39] . This has inspired Muller et al. to synthesize the analogous derivative 19, which has an amino function that can serve as an anchor for its conjugation with paramagnetic reporter groups to form MRI CAs targeted to inflammation [40] .
Reaction of 19 with DTPA-bisanhydride and subsequent complexation with Gd(III) produced conjugate 20 (Gd-DTPA-B(sLe x m)A) [40] . The 1 H NMRD profile showed that the relaxivity of this compound is almost the same as that of the parent system Gd-DTPA, which is surprising since the molecular weight of Gd-DTPA-B(sLe x m)A is higher [41] . An evaluation of the parameters x -E-selectin binding [38] . Compounds 19-21 are MRI contrast agents based on this inhibitor. Atoms in boxes are those involved in interactions with selectins. USPIO: Dextran-coated ultrasmall particle of iron oxide. 
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future science group governing the relaxivity shows that the residence time of water in the first coordination sphere (t M ) is not limiting the relaxivity. The unexpected low relaxivity might be the result of a relatively large distance between Gd(III) and the protons of the Gd-coordinated water molecule. Transmetallation experiments showed that Gd-DTPA-B(sLe x m)A is kinetically less stable than Gd-DTPA, but more stable than the commercial Gd-bisamide complex, Gd-DTPA-BMA. Furthermore, Gd-DTPA-B(sLe x m)A has no significant interaction with human serum albumin (HSA) and, therefore, competition of HSA during the targeting of E-selectin does not occur [41] .
The performance of the CA Gd-DTPA-B(sLe x m) A has been evaluated by in vivo pharmacokinetic and biodistribution studies on mice and rats in a fulminant hepatitis model [42] . A high specificity for E-selectin was confirmed by a significant and prolonged contrast enhancement between blood vessels and parenchyma in pathological conditions (FiguRe 8 ). The biodistribution of the compound showed its retention in inflamed liver and spleen by both specific mechanisms and accumulation due to necrotic lesions. The sialylmimetic 19 has also been grafted to the dextran coating of USPIO to give 21 (USPIO-sLe x m) [43] . Tests of the resulting new T 2 CA on cultured human umbilical vein cells (HUVECs) stimulated to express inflammatory adhesion molecules, showed that the nanoparticles recognized endothelial E-selectin. In vivo tests using T 2 -weighted images of healthy mice showed loss of intensity of the liver signal, since USPIOs are known to pass through the fenestrae of the liver and to be captured by Kupffer cells. On the contrary, a mouse model of hepatitis gave images with a significantly lower attenuation of the liver intensity, which suggests that the CA is retained extracellularly by selective interaction with endothelial E-selectin. Recently, the same mimetic was also coupled to carboxylated USPIOs that were coated with PEG to prolong the plasmacirculation time and to minimize the nonspecific accumulation of the particles in tissues [44] . The mean absolute concentration of iron oxide in inflamed muscles after injection of these particles was determined both ex vivo and in vivo by EPR. The efficacy of the grafted particles was improved by a factor of two, compared with the ungrafted particles. This was confirmed by a higher signal loss in MRI after administration of the grafted particles. Thus, USPIO-sLe x m particles may be very suitable for the MRI diagnosis of inflammation and for the in vitro evaluation of endothelial cell activation. This type of agent is also very promising for the early detection of endothelial activation in brain inflammation. They are able to detect E-selectin on the 'blood side' of the blood-brain barrier, which is indicative of a lesion on the 'brain side'. The principle was shown for Gd-DTPA-B(sLe x m)A, which gave a modest signal enhancement for activated endothelium in the brain [45, 46] . The aselective CA Gd-DTPA-BMA did not result in enhancement under the same conditions, showing that the blood-brain barrier was still intact. Van Kasteren et al. have synthesized a series of dextran-coated iron oxide nanoparticles, decorated with oligosaccharides of increasing carbohydrate complexity [47] . It appeared that only the nanoparticles conjugated with sLe x itself, (GNP-sLe x ; FiguRe 9 ; 22) targeted activated brain endothelium. With clinically relevant animal models, it was demonstrated that these particles are very sensitive negative CAs for early detection of endothelial activation by brain disease events. The lesions in question were not detectable with conventional MRI.
Another glycoprotein playing a role in inflammation is P-selectin, which is mainly expressed on the surface of activated platelets in, for example, cardiovascular diseases such as atherosclerosis and aneurism. Its main ligand is the sialomucin P-selectin glycoprotein ligand-1 (PSGL-1) expressed on the surface of lymphocytes. The recognition also involves the sLe x structural motif and, in addition, three sulfated tyrosine residues in the protein backbone. Chaubet et al. Reproduced with permission from [49] . [48] . Cytometry experiments on whole human blood and on platelets showed that the probe preferentially binds to activated platelets. No binding to other blood cells or resting platelets was observed. Furthermore, activated platelets incubated with CM8FS produced a bright MRI signal.
Hyaluronan as a targeting vector for CD44 receptors CD44, a receptor for hyaluronan, (HA; FiguRe 11 ; 24), is expressed in a variety of tumors such as breast, colon, intestinal, and brain, as well as melanoma, basal cell carcinoma and stem cells. Aime and coworkers designed and prepared a supramolecular adduct of anionic hyaluronan and cationic liposomes loaded with Gd-HPDO3A [49] . Tumor cell lines (C6, B-16-F10 and MCF-7) showed rapid uptake through receptor-mediated endocytosis, which could be visualized with MRI ( FiguRe 12) .
Targeting of sialic acid at surfaces of cancerous cells with Ln chelates conjugated with phenylboronic acids Sialic acids are known to be overexpressed on tumor cells, where they are present as terminal groups on oligosaccharide chains of glycolipids and glycoproteins [50, 51] . This phenomenon is related to the growing and spreading of the tumor. The sialic acid expression on tumor cells is approximately 1000 times higher than on healthy cells and, therefore, sialic acid is a good biomarker for the detection of cancer. Sialic acids comprise a family of 43 acidic 9-carbon sugars of which N-acetylneuraminic acid, (Neu5Ac, FiguRe 13; 25) , is the most common one. In glyco conjugates, it is usually a(2,3)-or a(2,6)-linked to galactose, galactosamine or to another sialic acid unit. Bertozzi and co-workers have exploited the sialoside biosynthetic pathway to metabolically modify naturally expressed sialic acid on human cells with a levulinoyl side chain (FiguRe 14; 27) . The terminal ketone group of the latter function was then utilized as a chemical target for covalent binding with the aminooxy anchor conjugated with Eu-DTPA chelate. [52] . By luminescence, it was demonstrated that 10 6 Eu chelates were targeted to normal Jurkat cells. A similar approach using the Gd analog might enable molecular imaging with MRI.
Neu5Ac is a structurally exceptional sugar unit in naturally occurring glycoconjugates because it has an exocyclic polyol function. This peculiarity can be exploited for its molecular recognition by boronates. Boronates can reversibly and covalently bind diol functions under the formation of five-and six-membered boronate esters [53] . The stability of these esters is for the greater part determined by their steric strain. Consequently, exocyclic diol functions, usually give rise to more stable esters. By has been shown that, under physiological conditions, only weak but selective binding of the OH functions of the pendant arm of this compound occurs [54] . Based on these ideas, several conjugates of Gd-DTPA were designed for the targeting of sialic acid residues [55] . Compounds 30-32 were selected for labeling studies on tumor cells [55, 56] . Compound 30 has a phenylboronic acid group for interaction with Neu5Ac, 31 has an NH 3 + function that can interact electrostatically with its COO -function, and 32 combines both structural features. Molecular modeling showed that the simultaneous interaction of the boronate and the NH 3 + in 32 is sterically feasible [54] . A gamma counting study on human glioma cells (2.3 × 10 15 moles/cell Neu5Ac) incubated with the radioactive 160 Tb complexes of 30-32 and of 29 ( 160 Tb-DTPA) showed that the kinetics of the increase of cell-associated activity shows the order 32 >> 30 > 31 > 29 (FiguRe 15) , which confirms the synergistic binding of Neu5Ac by the phenylboronate and ammonium functions. The essential role of Neu5Ac was demonstrated by an experiment in which the Neu5Ac at the glioma cell surface was enzymatically removed by sialidase. After treatment, the 160 Tb complexes no longer recognized the cells. Comparison of the binding of the 160 Tb label with human glioma tumor cells incubated with increasing concentrations of the 160 Tb-32 complex at 37°C with that at 4°C suggests that a considerable amount of the complex is taken up by cells at 37°C (FiguRe 16 ). Inductively coupled plasma atomic emission spectroscopy (ICP-AES) of lysates of the cells showed that the molar ratio terbium: boron is 1:1 rather than 1:2, as should be expected from the molecular structure of Tb-32. This indicates that a significant amount of Tb(III) is dissociated from the complex at the cell surface, which is in agreement with the known relatively low kinetic stability of Gd-DTPA-bisamide complexes. Previously, poor stability of another Gd-complex of a DTPA-bisamide, Gd-DTPA-BMA, was observed in cell experiments [57] .
Physiologically responsive probes
Sugar sensing with the use of MRI Quantification of the extent of glycation of HSA and hemoglobin provides a record of average mid-and long-term blood-sugar concentrations [58] , respectively. This is very useful for the management of diabetes [59] . In the presence of excessive levels of glucose (in diabetes patients), 
Responsive contRast agents
Category of targeted MRIcontrast agents that are able to act as reporters of the biological environment where they are distributed through parameters such as, for example, pH, partial oxygen pressure, degree of glycation of proteins, concentration of Ca 
420
future science group a nonenzymatic reaction between this and a free amino group of HSA takes place with the formation of a Schiff base. The latter spontaneously rearranges to the fructoseamine (FiguRe 17) . The sugar moieties of this compound occur as an equilibrium of the b-pyranose (58%; 33), a-furanose (19%; 34) and b-furanose (24%; 35) anomers [60] . The b-furanose 35 is perfectly preorganized for binding with phenylboronate and, consequently, fructosamine is strongly bound as phenylboronate ester 36 of this anomeric form. This ester is stabilized by an electrostatic interaction between the negatively charged boronate moiety and the neighboring positively charged ammonium function. A competition experiment with an equimolar amount of free glucose shows that the ratio of the resulting phenylboronate esters of fructosamine and glucose was greater than ten. The conjugate of phenylboronate and Gd-DTPA, (Gd-DTPA-BPBA; FiguRe 18 ; 37), has been applied as a responsive MRI CA for glycated HSA [61] . Binding of the boronic functions of Gd-DTPA-BPBA to the syndiol moieties of the fructosamine residues in glycated albumin, as described above, induces an enhancement of the water proton relaxation rate as a consequence of the increased rotational correlation time, t R . In this way, it is possible to map the glycation level of proteins in the blood (FiguRe 18) . A similar mechanism of interaction was observed for fructosamine model compounds with a conjugate of phenylboronic acid and a lanthanide DTPA derivative, in which the central pendant arm was replaced by the methylamide of l-lysine [62] . Unfortunately, this complex also shows a rather strong interaction with hexosefree HSA and, therefore, is not suitable for the determination of the degree of glycation of HSA.
Unexpectedly, the Gd-DTPA-BPBA complex was strongly bound by unglycated oxygenated human hemoglobin [63] . This interaction involves formation of coordinative N-B bonds at two histidine residues of different b-chains of the peptide. The interaction of the Gd(III) complex with hemoglobin is site specific and results in a conformational switch (from the low-affinity [T] to the high-affinity [R] state) in the tetrameric protein.
Sherry and co-workers have studied the interactions of a series of Eu(III) complexes of cyclen-based mono-and bis-(phenylboronate) ligands with glucose, galactose, fructose and lactose. The distance between the pendant boronate arms appears to be an important factor in determining the affinities for the various saccharides. The 1,7-disubstituted derivative 38 (Eu-DOTAM-2M-2PB; FiguRe 19 ) had a high and selective binding affinity for glucose (apparent stability constant of the resulting boronate ester: 339 ± 29 M -1 at pH 7) [64, 65] . The glucose is bound to the complex in a 1:1 fashion by forming a bridge above the Eu(III)-bound water molecule (FiguRe 19 ). Upon encapsulation with glucose, the exchange of the Eu(III)-bound water and the bulk water slows down by a factor of two. The exchange rate then is sufficiently slow on the NMR time scale to permit presaturation of the 1 H resonance of the Eu(III)-bound water resonance, in order to modulate the intensity of the bulk water through paramagnetic chemical exchange saturation transfer (PARACEST) and, thus, the contrast in an MR image. Therefore, this system can be used for the imaging of the tissue distribution of glucose. This has been demonstrated by CEST images of livers perfused in the magnet [66] . The CEST images responded to the glucose concentrations, which were altered by stimulation of glycogenolysis by the hormone glucagon, for example The binding strength of the system to glycated HSA is of the same order of magnitude as that of glucose. Since the plasma concentration of this material is normally relatively low, this should not interfere with the use of the complex as a glucose sensor. On the other hand, the good affinity for glycated HSA allows the in vitro determination of the degree of glycation in serum, using MRI and high-throughput methods [65] .
It should be noted that Eu-DOTAM-2M-2PB is a positively charged compound. Positively charged lanthanide complexes are toxic for in vivo studies, which was confirmed by initial injections into mice [66] . A modified sensor with additional negatively charged carboxyl groups on the nonfunctional amide side chains has been reported to have similar CEST sensitivity to glucose and no clinical signs of toxicity in mice [67] .
Detection of enzymatic activity by MRI Increased activity of certain enzymes has been described as an indication of the progression of many types of cancer. The methods used to measure this activity are, however, often difficult to 
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future science group employ in biological environments. This stimulates the search for physio logically responsive probes that can be activated to report on the metabolic state of cells and organs by MRI. The first example of a biologically activated CA consisting of Gd-HPDO3A conjugated to a b-galactose moiety (41) was reported by Meade and co-workers already some years ago ( FiguRe 21 ) [68] . Initially, b-galactose was serving as a steric obstacle for water molecules to enter the inner coordination sphere at the metal center (q = 0). After cleavage of the sugar by the enzyme b-galactosidase, the hydroxyl group becomes available for coordination of Gd(III) and the open space allows one water molecule to enter the coordination cage (q = 1), with a 20% increase in relaxivity as a consequence. This 'switching on' of the MRI activity of the CA was then used to monitor b-galactosidase activity, as this enzyme is commonly used as a marker to follow the regulation of individual genes, such as in transgenic animals. Compound 42 was shown to be useful for in vitro and in vivo (Xenopus laevis embryos) visualization and localization of gene expression by MRI [69] . However, results from the biodistribution of the analogue 111 In(III)-radiolabeled compound in mice revealed that most of the tracer was located in the liver (taken up by ASGP-R) already, 2 h postinjection [37] . This approach was further exploited in the development of in vitro assays for the determination of the activity of b-glucuronidase [70] , an enzyme with enhanced extracellular concentration around tumors and involved in the liberation of b-glucuronic acid during the mono-prodrug therapy. For this purpose, the Gd-DO3A chelate was conjugated with a b-glucuronic acid moiety, via a self-immolative nitrodihydroxybenzyl linker. Enzymatic hydrolysis of b-glucoronic acid triggers a cascade reaction that releases the Gd chelate, the bridging arm and CO 2 , changing the hydration number from 0 to 1 and, thus, increasing relaxivity.
This work has inspired Tóth and co -workers to design an enzyme-responsive CA for PARACEST application [71] . Benzylocarbamate was used as a future science group self-immolative linker, connecting a Yb-DOTA unit through an a-carbamoyl nitrogen and b-dgalactopyranoside 43. As the result of the attack by b-galactosidase, the electron cascade is initiating the cleavage of carbamate, followed by transformation into an amine. The slowly exchanging magnetically non equivalent amine protons were used to generate the PARACEST effect. This novel class of CAs has a great potential for detection of a variety of enzymes by a simple change of the glycosubstrate.
Future perspective
The rapid recent progress in glycobiology opens new avenues for the design of novel CAs based on molecular recognition of sugar moieties. The examples described in this review show that saccharides can be used both as targets and as targeting vectors. The structures of the compounds involved are relatively complicated and the synthesis of systems involving oligosaccharide moieties is particularly difficult. On the other hand, it may be expected that the developments in automated synthesis and in purification techniques will facilitate the development of efficient CAs for molecular imaging with the use of MRI. A general problem with molecular imaging is that the concentration of biomarkers of diseases usually is very low, particularly considering the intrinsic low sensitivity of MRI CAs. Therefore, amplification strategies to push up the sensitivity by introducing new MRI techniques, such as CEST, and delivering high payloads of paramagnetic metal ions at the sites of interests are of utmost importance [72] . It may be expected that nanoparticulate systems will play an important role in this respect [73] . Another important issue is that the magnetic-field strengths of the MRI equipment used for medical diagnosis are increasing. Most current MRI CAs have optimum performance at relatively low fields (<1.5 T). T 2 CAs show increasing relaxivity upon increasing magnetic field strength [74] and, therefore, this class of agents may gain further importance in the future.
The cost of commercialization of MRI CAs is huge, mainly due to the extremely high costs of the preclinical and clinical tests required. During the coming years, many new CAs will be developed in the laboratory, but only a few of the most promising ones will enter the stage of clinical tests. An important strategy to reduce the development costs is to build up the new molecular imaging CAs from a limited number of efficient reporting modules and a variety of targeting vectors, using efficient conjugation reactions, such as click reactions [75] .
In vitro applications of responsive MRI CAs may have great potential in medical diagnosis, particularly in combination with high-throughput methods. 
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Executive summary
In the field of molecular contrast agents new MRI contrast agents are emerging that are based on molecular recognition of carbohydrates. These agents have promising properties, which may be exploited in diagnostics for both in vivo and in vitro applications.
Glycoconjugates play an important role in many biological processes and, consequently, these compounds are attractive targets for diagnostic agents. Important targets that are already identified in this field are the asialoglycoprotein receptor and the selectins, which can be targeted by ligands conjugated to galactosyl groups and Sialyl-Lewis X mimics, respectively.
Boronates are interesting artificial targeting vectors for sugars. Conjugates of lanthanide chelates and phenylboronic acid have been designed that can be applied for the molecular imaging of sialic acid, a sugar residue in glycoconjugates, which is overexpressed in tumors.
Conjugates of lanthanide chelates and phenylboronic acid have also been successfully applied as responsive contrast agents for glycated human serum albumin and for glucose. This type of agents has found applications both in vitro and in vivo.
MRI studies of perfused liver have shown that the combination of paramagnetic MRI contrast agents of this type and new MRI techniques, such as paramagnetic chemical exchange saturation transfer, have a great potential for the efficient mapping of the distribution of glucose in tissues.
